Ryutaro Kakinuma

Summary

Affiliation: National Cancer Center
Country: Japan

Publications

  1. pmc Comparison of sensitivity of lung nodule detection between radiologists and technologists on low-dose CT lung cancer screening images
    R Kakinuma
    Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
    Br J Radiol 85:e603-8. 2012
  2. doi request reprint Measurement of focal ground-glass opacity diameters on CT images: interobserver agreement in regard to identifying increases in the size of ground-glass opacities
    Ryutaro Kakinuma
    National Cancer Center, Tokyo, Japan
    Acad Radiol 19:389-94. 2012
  3. doi request reprint Performance evaluation of 4 measuring methods of ground-glass opacities for predicting the 5-year relapse-free survival of patients with peripheral nonsmall cell lung cancer: a multicenter study
    Ryutaro Kakinuma
    National Cancer Hospital East, Kashiwa, Chiba, Japan
    J Comput Assist Tomogr 32:792-8. 2008
  4. ncbi request reprint Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy
    Kiyotaka Yoh
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Lung Cancer 58:73-9. 2007
  5. ncbi request reprint Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial
    Seiji Niho
    Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwanoha 6 5 1, Kashiwa, 277 8577 Chiba, Japan
    Cancer Chemother Pharmacol 52:19-24. 2003
  6. ncbi request reprint Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity
    Kiyotaka Yoh
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Lung Cancer 55:337-41. 2007
  7. ncbi request reprint Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer
    Ryutaro Kakinuma
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwa no ha, Kashiwa, Chiba 277 8577, Japan
    J Comput Assist Tomogr 28:17-23. 2004
  8. ncbi request reprint High body mass index correlates with increased risk of venous irritation by vinorelbine infusion
    Kiyotaka Yoh
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Jpn J Clin Oncol 34:206-9. 2004
  9. ncbi request reprint Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma
    Kiyotaka Yoh
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Cancer 98:926-31. 2003
  10. ncbi request reprint First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study
    Seiji Niho
    Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Clin Oncol 24:64-9. 2006

Detail Information

Publications26

  1. pmc Comparison of sensitivity of lung nodule detection between radiologists and technologists on low-dose CT lung cancer screening images
    R Kakinuma
    Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
    Br J Radiol 85:e603-8. 2012
    ..The objective of this study was to compare the sensitivity of detection of lung nodules on low-dose screening CT images between radiologists and technologists...
  2. doi request reprint Measurement of focal ground-glass opacity diameters on CT images: interobserver agreement in regard to identifying increases in the size of ground-glass opacities
    Ryutaro Kakinuma
    National Cancer Center, Tokyo, Japan
    Acad Radiol 19:389-94. 2012
    ..To evaluate interobserver agreement in regard to measurements of focal ground-glass opacities (GGO) diameters on computed tomography (CT) images to identify increases in the size of GGOs...
  3. doi request reprint Performance evaluation of 4 measuring methods of ground-glass opacities for predicting the 5-year relapse-free survival of patients with peripheral nonsmall cell lung cancer: a multicenter study
    Ryutaro Kakinuma
    National Cancer Hospital East, Kashiwa, Chiba, Japan
    J Comput Assist Tomogr 32:792-8. 2008
    ..To evaluate the performance of 4 methods of measuring the extent of ground-glass opacities as a means of predicting the 5-year relapse-free survival of patients with peripheral nonsmall cell lung cancer (NSLC)...
  4. ncbi request reprint Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy
    Kiyotaka Yoh
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Lung Cancer 58:73-9. 2007
    ..There were no treatment-related deaths. The combination of carboplatin plus paclitaxel is an active and well-tolerated regimen for the treatment of NSCLC patients who have previously been treated with chemotherapy and have a good PS...
  5. ncbi request reprint Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial
    Seiji Niho
    Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwanoha 6 5 1, Kashiwa, 277 8577 Chiba, Japan
    Cancer Chemother Pharmacol 52:19-24. 2003
    ..We conducted a phase I/II trial of gemcitabine and docetaxel in patients with recurrent NSCLC after platinum-based chemotherapy and with an ECOG performance status (PS) of 0 or 1...
  6. ncbi request reprint Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity
    Kiyotaka Yoh
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Lung Cancer 55:337-41. 2007
    ..Further studies for the control of local venous toxicity of vinorelbine are warranted...
  7. ncbi request reprint Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer
    Ryutaro Kakinuma
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwa no ha, Kashiwa, Chiba 277 8577, Japan
    J Comput Assist Tomogr 28:17-23. 2004
    ..To clarify the progression of focal pure ground-glass opacity (pGGO) detected by low-dose helical computed tomography (CT) screening for lung cancer...
  8. ncbi request reprint High body mass index correlates with increased risk of venous irritation by vinorelbine infusion
    Kiyotaka Yoh
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Jpn J Clin Oncol 34:206-9. 2004
    ..We conducted this study to identify clinical risk factors related to the incidence of venous irritation caused by peripheral vinorelbine infusion...
  9. ncbi request reprint Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma
    Kiyotaka Yoh
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Cancer 98:926-31. 2003
    ..The purpose of the current study was to determine the efficacy and tolerability of a weekly chemotherapy regimen consisting of cisplatin, vincristine, doxorubicin, and etoposide (CODE) for the treatment of advanced thymic carcinoma...
  10. ncbi request reprint First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study
    Seiji Niho
    Division of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    J Clin Oncol 24:64-9. 2006
    ..We conducted a phase II study of single agent treatment with gefitinib in chemotherapy-naïve patients with advanced non-small-cell lung cancer (NSCLC) to assess its efficacy and toxicity...
  11. ncbi request reprint Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer
    Seiji Niho
    Division of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan
    Jpn J Clin Oncol 34:69-73. 2004
    ..Therefore, febrile neutropenic inpatients are empirically treated with intravenous broad-spectrum antibiotics. Recently, several studies have suggested the presence of low-risk groups among febrile neutropenic patients...
  12. ncbi request reprint Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience
    Junji Yoshida
    Department of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    J Thorac Cardiovasc Surg 129:991-6. 2005
    ..This study was undertaken to determine the recurrence rate after limited resection of small lung carcinoma and to evaluate intraoperative frozen-section examination accuracy for Noguchi classification...
  13. ncbi request reprint Cushing's syndrome associated with adenocarcinoma of the lung
    Kiyotaka Yoh
    Thoracic Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba
    Intern Med 42:831-3. 2003
    ..This is a very rare case report of Cushing's syndrome associated with adenocarcinoma of the lung...
  14. ncbi request reprint Localized pure ground-glass opacity on high-resolution CT: histologic characteristics
    Ryu Nakajima
    Pathology Division, National Cancer Center Research Institute East, Chiba, Japan
    J Comput Assist Tomogr 26:323-9. 2002
    ..The diameter of the nonaerogenous components varied between 0.2 and 2.0 mm. CONCLUSION: Because 10% of LPGGO lesions include invasive disease, patients with LPGGO should undergo pathologic examination for confirmation...
  15. ncbi request reprint Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project
    Tomotaka Sobue
    Cancer Information and Epidemiology Division, National Cancer Center Research Institute, National Cancer Center Hospital, Tokyo, Japan
    J Clin Oncol 20:911-20. 2002
    ..To provide data on screening performance of low-dose helical computed tomography (CT) scanning and its efficacy in terms of survival, a one-arm longitudinal screening project was conducted...
  16. doi request reprint Low-dose CT screening for lung cancer with automatic exposure control: phantom study
    Shiho Gomi
    Department of Cancer Screening Technology and Development, National Cancer Center Research Center for Cancer Prevention and Screening, Tokyo, Japan
    Radiol Phys Technol 1:244-50. 2008
    ..038), and lung base (p < 0.022) in the scan conditions using CT-AEC with the DR-Wedge. We achieved improvement of image quality without increasing the collective dose by using CT-AEC with the DR-Wedge under low-dose scan conditions...
  17. ncbi request reprint Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients?
    Hironobu Minami
    Division of Oncology Hematology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa 277 8577, Japan
    J Clin Oncol 22:2901-8. 2004
    ..To elucidate the mechanism of the difference, the pharmacokinetics of docetaxel and cisplatin were investigated in two phase II studies separately conducted in elderly and non-elderly patients...
  18. ncbi request reprint A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC)
    Satoshi Ishikura
    Division of Radiation Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwa noha, Kashiwa 277 8577, Japan
    Int J Radiat Oncol Biol Phys 61:1117-22. 2005
    ..The purpose was to assess the feasibility and efficacy of hyperfractionated accelerated radiotherapy (HART) after induction chemotherapy for Stage III non-small-cell lung cancer...
  19. doi request reprint Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report
    Takashi Terauchi
    Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5 1 1 Tsukiji, Chuo Ku, Tokyo 104 0045, Japan
    Ann Nucl Med 22:379-85. 2008
    ..Even the screening accuracy for whole-body screening using FDG-PET has not been evaluated. In this study, we investigated the screening accuracy of PET cancer screening...
  20. ncbi request reprint Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer
    Seiji Niho
    Division of Thoracic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
    Lung Cancer 35:209-14. 2002
    ..A randomized phase III trial is warranted to compare this 3 consecutive weeks protocol with administration of docetaxel and cisplatin every third week...
  21. ncbi request reprint Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria
    William D Travis
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Thorac Oncol 1:S13-9. 2006
    ..Advances in the pathology and computed tomography (CT) of lung adenocarcinoma and bronchioloalveolar carcinoma (BAC) have demonstrated important new prognostic features that have led to changes in classification and diagnostic criteria...
  22. ncbi request reprint [An assessment of the potential for interpretation of CT images by radiological technologists]
    Toru Matsumoto
    Nihon Hoshasen Gijutsu Gakkai Zasshi 61:791-9. 2005
  23. ncbi request reprint [Lung cancer screening using low-dose helical CT]
    Hironobu Ohmatsu
    Division of Thoracic Oncology, National Cancer Center Hospital East
    Nihon Rinsho 60:653-6. 2002
  24. ncbi request reprint Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma
    William D Travis
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 23:3279-87. 2005
    ..To review recent advances in pathology and computed tomography (CT) of lung adenocarcinoma and bronchioloalveolar carcinoma (BAC)...
  25. ncbi request reprint Computer-simulation technique for low dose computed tomographic screening
    Kouzou Hanai
    Division of Diagnosis Radiology, National Hospital Organization Kanagawa Hospital, Kanagawa, Japan
    J Comput Assist Tomogr 30:955-61. 2006
    ..The purpose of this study is to assess the relative influence of noise and artifact in detecting lung nodules on low dose computed tomographic (CT) screening...
  26. ncbi request reprint Optimized control of X-ray exposure and image noise using a particular multislice CT scanner
    Shuji Yamamoto
    National Cancer Center, Research Center for Cancer Prevention and Screening 3rd Term Comprehensive 10 Year Strategy for Cancer Control
    Nihon Hoshasen Gijutsu Gakkai Zasshi 64:955-9. 2008
    ..In conclusion, nDNR can be applied to patient dose reduction while keeping an acceptable image quality using a particular 4-row MSCT scanner...